SteinCares
  • Home
  • Company
    • Who We are
    • Our Milestones
    • Our Presence
  • Business Segments
    • Innovative
    • Biosimilars
    • Complex Generics
    • Therapeutic Areas
  • Partnerships
    • Pillars of Successful Partnerships
    • Our Partnership Solutions
  • Press Releases
  • Contact us
  • ESP
Select Page
Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America

Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America

by victoria.carrillo | Jun 24, 2025 | Press Releases

This new agreement marks the fourth product in the partnership and introduces a potential cost-effective alternative to one of the world’s top-selling biologics—broadening access to specialty care for patients with chronic inflammatory diseases. The partnership...
Bio-Thera Solutions and SteinCares Expand Partnership with Addition of a Third Biosimilar in LATAM 

Bio-Thera Solutions and SteinCares Expand Partnership with Addition of a Third Biosimilar in LATAM 

by victoria.carrillo | Dec 19, 2024 | Press Releases

GUANGZHOU, China and San Jose, Costa Rica – SteinCares, a leading specialty healthcare company in Latin America, and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced an expansion...
Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM

Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM

by victoria.carrillo | Mar 18, 2024 | Press Releases

Guangzhou, China and San José, Costa Rica – Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, and SteinCares, one of Latin America’s leading specialty healthcare companies, announced today a new...

Recent Posts

  • SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil
  • SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America
  • SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance
  • SteinCares Expands its Portfolio in Brazil with Monofer®
  • SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America

Recent Comments

No comments to show.